SCHEMBL6274733

SCHEMBL6274733

CCCCCC/C=C/Oc1c(O)c2cccc(OCC(=O)O)c2oc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.41
PSEN1 P49768 3/20 0.38
PSEN2 P49810 3/20 0.38
APH1B Q8WW43 3/20 0.38
NCSTN Q92542 3/20 0.38
APH1A Q96BI3 3/20 0.38
PSENEN Q9NZ42 3/20 0.38
TBXA2R P21731 5/20 0.37
PTGIR P43119 5/20 0.37
FHIT P49789 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CNR2 P34972 1/20 0.36
EPHX2 P34913 1/20 0.36
PPARG P37231 1/20 0.36
MIF P14174 1/20 0.36
LTB4R Q15722 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6274736 1.00 PPARA (0.41) PPARAPSEN1PSEN2APH1BNCSTN
SCHEMBL6274505 1.00 PPARA (0.41) PPARAPSEN1PSEN2APH1BNCSTN
SCHEMBL6274509 1.00 PPARA (0.41) PPARAPSEN1PSEN2APH1BNCSTN
SCHEMBL6277144 0.97 PPARA (0.38) PPARAPSEN1PSEN2APH1BNCSTN
SCHEMBL6277137 0.97 PPARA (0.38) PPARAPSEN1PSEN2APH1BNCSTN
SCHEMBL6275152 0.92 LTB4R (0.41) PPARACNR2EPHX2LTB4R
SCHEMBL6275150 0.92 LTB4R (0.41) PPARACNR2EPHX2LTB4R
SCHEMBL6275631 0.91 LTB4R (0.43) PPARATBXA2RALDH1A1HPGDKDM4E
SCHEMBL6275632 0.91 LTB4R (0.43) PPARATBXA2RALDH1A1HPGDKDM4E
SCHEMBL6276928 0.89 ALDH1A1 (0.40) TBXA2RPTGIRFHITALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 PPARA 2170/4885PSEN1 3767/4885PSEN2 4569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.